FTCR: Affordable Therapy, Strong Public Oversight, Diverse Research
Publicly financed stem cell research may be a "gold mine" for biotech companies, but California taxpayers should not "get the shaft," the California Foundation for Taxpayer and Consumer Rights said today.
Jerry Flanagan, health care policy director for the group, said in a statement that the California stem cell agency should ensure that taxpayers and pa…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.